Metropolitan Life Insurance Company (MetLife)’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-463
| Closed | -$103K | – | 2371 |
|
|
2021
Q4 | $103K | Buy |
463
+24
| +5% | +$5.32K | ﹤0.01% | 2462 |
|
|
2021
Q3 | $152K | Buy |
+439
| New | +$152K | ﹤0.01% | 2283 |
|
|
2021
Q2 | – | Sell |
-415
| Closed | -$129K | – | 2754 |
|
|
2021
Q1 | $129K | Buy |
415
+39
| +10% | +$12.1K | ﹤0.01% | 2308 |
|
|
2020
Q4 | $94K | Sell |
376
-62
| -14% | -$15.5K | ﹤0.01% | 2383 |
|
|
2020
Q3 | $81K | Hold |
438
| – | – | ﹤0.01% | 2342 |
|
|
2020
Q2 | $109K | Buy |
438
+26
| +6% | +$6.49K | ﹤0.01% | 2201 |
|
|
2020
Q1 | $74.6K | Buy |
412
+1
| +0.2% | +$181 | ﹤0.01% | 2219 |
|
|
2019
Q4 | $171K | Buy |
+411
| New | +$171K | ﹤0.01% | 2030 |
|